Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis

The study hypothesis is that a quantitative index can be derived from Tc-99m myocardial perfusion scans that accurately identifies the presence of left ventricular hypertrophy and pulmonary hypertension. Echocardiography provides the reference standard.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pulmonary Hypertension Cardiovascular Diseases Hypertension Hypertension, Pulmonary Lung Diseases Respiratory Tract Diseases Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Cincinnati

Cincinnati, Ohio, 45267, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Must have an interpretable Tc-99m myocardial perfusion scan and an interpretable echocardiogram.

Exclusion criteria

Technically inadequate noninvasive test.

Treatment and study plan

Diagnostic imaging procedures.

Other

Primary outcomes

Sensitivity and specificity of quantitation of Tc-99m perfusion scans for identification of pulmonary hypertension.

Time frame: 2 years

Sponsors and collaborators

Lead sponsor

University of Cincinnati

Other

Registry information

Official study title

Right Ventricular Hypertrophy and Pulmonary Hypertension: A Correlation Analysis Between Tc-99m Tetrofosmin SPECT Adn Echocardiography

Important dates

Study start: 2008
Primary completion: 2009
First posted: Apr 6, 2009
Registry last updated: Apr 6, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed